Doctor profile · Federal record
Dr. Mark Reed, MD
Gynecologic Oncology Physician (CMS: Gynecological Oncology) · Gynecologic Oncology Physician · Gynecologic Oncology Physician · Germantown, TN
- NPI 1477585347
- Accepts Medicare
- MIPS 86.1 / 100 · 2023
- 39 yrs in practice
- Licensed in 3 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
7945 Wolf River Blvd
Germantown, TN 381381762
(901) 683-0055
fax (901) 685-9718 - Mailing address
-
7714 Poplar Ave Ste 200
Germantown, TN 381383941
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- January 25, 2022
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207VX0201X — NUCC code
- State licenses (3)
- Tennessee #20450 · Arkansas #E3415 · Mississippi #18303
- Medicaid (5)
- AR #142235001 · MS #00770531 · MO #205175300 · MS #00123498 · TN #3858084
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1477585347. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
212,922
Distinct HCPCS
10
Medicare allowed
$2,839,820
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 66,750 | 62 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 20,700 | 46 | $54 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 16,940 | 50 | $3 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 16,800 | 30 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 15,038 | 36 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 8,520 | 83 | $23 | |
J1442 |
Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 8,520 | 12 | $1 | |
J9025 |
Injection, azacitidine, 1 mg | 8,100 | 13 | $0 | |
Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 6,590 | 31 | $28 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 5,760 | 15 | $48 |
In context: peer comparison
Among 2 peers in Germantown Gynecologic Oncology Physician, average services per provider: 1,856. This provider delivers 115× the peer median.Open Payments
Industry payments received
All-time total
$731
Transactions
24
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $161.65 | |
| Eisai INC. | 1 | $121.85 | |
| Astellas Pharma US INC | 1 | $121.26 | |
| Merck Sharp & Dohme LLC | 5 | $118.47 | |
| AstraZeneca Pharmaceuticals Lp | 3 | $57.99 | |
| Tempus Ai, INC | 1 | $29.27 | |
| Abbvie INC. | 1 | $23.68 | |
| Ethicon US, LLC | 1 | $23.30 | |
| Geron Corporation | 1 | $21.12 | |
| Pfizer INC. | 1 | $19.87 | |
| Rigel Pharmaceuticals, INC. | 1 | $17.75 | |
| Novartis Pharmaceuticals Corporation | 1 | $14.59 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
821
Patients
424
Total drug cost
$678,167
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Estradiol | Generic | 124 | 41 | $12,704 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 94 | 81 | $911 |
| Letrozole | Generic | 82 | 20 | $2,047 |
| Potassium Chloride | Generic | 82 | 23 | $1,365 |
| Ondansetron Odt (Ondansetron) | Brand | 74 | 73 | $511 |
| Megestrol Acetate | Generic | 62 | 31 | $2,628 |
| Gabapentin | Generic | 60 | 17 | $599 |
| Dexamethasone | Generic | 45 | 35 | $1,009 |
| Progesterone (Progesterone, Micronized) | Brand | 39 | 14 | $1,997 |
| Prochlorperazine Maleate | Generic | 36 | 30 | $1,210 |
Hospital affiliations
Frequently asked questions
What is Dr. Mark Reed's medical specialty?
Dr. Mark Reed practices Gynecologic Oncology Physician in Germantown, TN.
Where does Dr. Mark Reed practice?
Dr. Mark Reed practices at 7945 Wolf River Blvd, Germantown, TN 381381762. Office phone: 9016830055.
What is Dr. Mark Reed's NPI?
Dr. Mark Reed's National Provider Identifier (NPI) is 1477585347, issued by NPPES.
Does Dr. Mark Reed accept Medicare assignment?
Yes. Dr. Mark Reed accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Reed commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881). Source: CMS Medicare Physician & Other Practitioners file.